Loading...
Header Logo
Keywords
Last Name

Connection

Search Results to Caio Max Sao Pedro Rocha Lima, M.D., M.S.

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Rocha Lima, Caio Max

Item TypeName
Concept Antibodies, Monoclonal
Academic Article Phase Ib study of drozitumab combined with first-line mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer.
Academic Article New therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathways.
Academic Article A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
Academic Article Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer.
Academic Article Advanced or metastatic pancreatic cancer: molecular targeted therapies.
Academic Article Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapy.
Academic Article Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.
Academic Article New directions in the management of advanced pancreatic cancer: a review.
Academic Article Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinoma.
Academic Article EGFR targeting of solid tumors.
Academic Article Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.

Search Criteria
  • Antibodies Monoclonal